The heparin-binding proteins apolipoprotein E and lipoprotein lipase enhance cellular proteoglycan production

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 1, 2000, Pages 111-118

  Obunike, Joseph C ^a,e   Pillarisetti, Sivaram ^a   Paka, Latha ^a   Kako, Yuko ^a   Butteri, Mathew J ^a   Ho, Yuan Yaun ^a   Wagner, William D ^b   Yamada, Nobuhiro ^c   Mazzone, Theodore ^d   Deckelbaum, Richard J ^a   Goldberg, Ira J ^a  

^a Columbia Univ Coll Phys/Surgs ^*  (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d RUSH MEDICAL COLLEGE   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Atherosclerosis; Chondroitin; Glycosaminoglycans; Heparan; Macrophages

Indexed keywords

APOLIPOPROTEIN E; CHONDROITIN; GLYCOSAMINOGLYCAN; HEPARAN; HEPARIN BINDING PROTEIN; LIPOPROTEIN LIPASE; PROTEOGLYCAN;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVITY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS;

EID: 0033958212     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.1.111     Document Type: Article

References (65)

1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622-630.
2. Plump AS, Breslow JL. Apolipoprotein E and the apolipoprotein E-deficient mouse. Annu Rev Nutr. 1995;15:495-518.
3. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res. 1996;37:693-707.
4. Olivecrona G, Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipidol. 1995;6:291-305.
5. Beisiegel U, Weber W, Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci U S A. 1991;88:8342-8346.
6. Chappell DA, Fry GL, Waknitz MA, Iverius PH, Williams SE, Strickland DK. The low density lipoprotein receptor-related protein/α2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase. J Biol Chem. 1992;267:25764-25767.
7. Willnow TE, Goldstein JL, Orth K, Brown MS, Herz J. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J Biol Chem. 1992;276: 26172-26180.
8. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343-353.
9. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468-471.
10. Weinstock PH, Bisgaier CL, Aalto-Setala K, Radner H, Ramakrishnon R, Levak-Frank S, Essenberg AD, Zechner R, Breslow JL. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice: mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J Clin Invest. 1995;96:2555-2568.
11. Coleman T, Seip RL, Gimble JM, Lee D, Maeda N, Semenkovich CF. COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity. J Biol Chem. 1995;270:12518-12525.
12. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Goldberg IJ, Steinberg D, Witztum JL. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc Nat Acad Sci U S A. 1991;88:10143-10147.
13. O'Brien KD, Gordon D, Deeb S, Ferguson M, Chait A. Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J Clin Invest. 1992;89:1544-1550.
14. Basu SK, Ho YK, Brown MS, Bilheimer DW, Anderson RGW, Goldstein JL. Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes. J Biol Chem. 1982;257: 9788-9795.
15. Yin B, Loike JD, Kako Y, Weinstock PH, Breslow JL, Silverstein SC, Goldberg IJ. Lipoprotein lipase regulates Fc receptor-mediated phagocytosis by macrophages maintained in glucose-deficient medium. J Clin Invest. 1997;100:649-657.
16. Williams DL, Dawson PA, Newman TC, Rudel LL. Synthesis of apolipoprotein E by peripheral tissues: potential functions in reverse cholesterol transport and cellular cholesterol metabolism. Ann N Y Acad Sci. 1985;454:222-229.
17. Fielding CJ, Frohlich J, Moser K, Fielding PE. Promotion of sterol efflux and net transport by apolipoprotein E in lecithin:cholesterol acyltransferase deficiency. Metabolism. 1982;31:1023-1028.
18. Mazzone T, Reardon CA. Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3. J Lipid Res. 1994;35:1345-1353.
19. Bellosta S, Mahley RW, Sanan DA, Murata J, Newland DL, Taylor JM, Pitas RE. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J Clin Invest. 1995;96:2170-2179.
20. Kjellen L, Lindahl U. Proteoglycans: structures and interactions. Annu Rev Biochem. 1991;60:443-475.
21. Hardingham TE, Fosang AJ. Proteoglycans: many forms and many functions. FASEB J. 1992;6:861-870.
22. Orellana A, Hirschberg CB, Wei Z, Swiedler SJ, Ishihara M. Molecular cloning and expression of a glycosaminoglycan N-acetylglucosaminyl N-deacetylase/N-sulfotransferase from a heparin-producing cell line. J Biol Chem. 1994;269:2270-2276.
23. Habuchi H, Habuchi O, Kimata K. Purification and characterization of heparan sulfate 6-sulfotransferase from the culture medium of Chinese hamster ovary cells. J Biol Chem. 1995;270:4172-4179.
24. Dixon J, Loftus SK, Oladwin AJ, Scambler PJ, Wasmuth JJ, Dixon MJ. Cloning of the human heparan sulfate-N-deacetylase/N-sulfotransferase gene from the Treacher Collins syndrome candidate region at 5q32-q33.1. Genomics. 1995;26:239-244.
25. Fukuta M, Uchimura K, Nakashima K, Kato M, Kimata K, Shinomura T, Habuchi O. Molecular cloning and expression of chick chondrocyte chondroitin 6-sulfotransferase. J Biol Chem. 1995;270:18575-18580.
26. Kobayashi M, Habuchi H, Yoneda M, Habuchi O, Kimata K. Molecular cloning and expression of Chinese hamster ovary cell heparan-sulfate 2-sulfotransferase. J Biol Chem. 1997;272:13980-13985.
27. Rosenberg RD, Shworak NW, Liu J, Schwartz JJ, Zhang L. Heparan sulfate proteoglycans of the cardiovascular system: specific structures emerge but how is synthesis regulated? J Clin Invest. 1997;99: 2062-2070.
28. Prinz R, Schwermann J, Buddecke E, von Figura K, Endocytosis of sulphated proteoglycans by cultured skin fibroblasts. Biochem J. 1978; 176:671-676.
29. Vogel KG, Kendall VF. Cell-surface glycosaminoglycans: turnover in cultured human embryo fibroblasts (IMR-90). J Cell Physiol. 1980;103: 475-487.
30. Glimelius B, Norling B, Westermark B, Wasteson A, Turnover of cell surface associated glycosaminoglycans in cultures of human normal and malignant glial cells. Exp Cell Res. 1978;117:179-189.
31. Yanagishita M, Hascall VC. Metabolism of proteoglycans in rat ovarian granulosa cell culture: multiple intracellular degradative pathways and the effect of chloroquine. J Biol Chem. 1984;259:10270-10283.
32. Yanagishita M, Hascall VC. Cell surface heparan sulfate proteoglycans. J Biol Chem. 1992;267:9451-9454.
33. Uhlin-Hansen L, Yanagishita M, Brefeldin A inhibits the endocytosis of plasma-membrane-associated heparan sulphate proteoglycans of cultured rat ovarian granulosa cells. Biochem J. 1995;310:271-278.
34. Obunike JC, Edwards IJ, Rumsey SC, Curtiss LK, Wagner WD, Deckelbaum RJ, Goldberg IJ. Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins. J Biol Chem. 1994;269:13129-13135.
35. Obunike JC, Pillarisetti S, Paka L, Low MG, Goldberg IJ. Lipoprotein lipase degradation by adipocytes: receptor-associated protein (RAP)-sensitive and proteoglycan-mediated pathways. J Lipid Res. 1996;37: 2439-2449.
36. Saxena U, Klein MG, Goldberg IJ. Metabolism of endothelial cell-bound lipoprotein lipase: evidence for heparan sulfate proteoglycan-mediated internalization and recycling. J Biol Chem. 1990;265:12880-12886.
37. Mazzone T, Pustelnikas L, Reardon CA. Post-translational regulation of macrophaae apoprotein E production. J Biol Chem. 1992;267:1081-1087.
38. Talmage DA, Lackey RS. Retinoic acid receptor α suppresses polyomavirus transformation and c-fos expression in rat fibroblasts. Oncogene. 1992;7:1837-1845.
39. Wigler M, Sweet R, Sim GK, Wold B, Pellicer A, Lacy E, Maniatis T, Silverstein S, Axel R. Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell. 1979;16:777-785.
40. Kawamura M, Shimano H, Gotoda T, Harada K, Shimada M, Ohsuga J, Inaba T, Watanabe Y, Yamamoto K, Kozaki K, Yazaki Y, Yamada N. Overexpression of human lipoprotein lipase enhances uptake of lipoproteins containing apolipoprotein B-100 in transfected cells. Arterioscler Thromb. 1994;14:235-242.
41. Nilsson-Ehle P, Schotz MC. A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res. 1976;17:536-541.
42. Pang L, Sivaram P, Goldberg IJ. Cell-surface expression of an amino-terminal fragment of apolipoprotein B increases lipoprotein lipase binding to cells. J Biol Chem. 1996;271:19518-19523.
43. Edwards IJ, Wagner WD. Distinct synthetic and structural characteristics of proteoglycans produced by cultured artery smooth muscle cells of atherosclerosis-susceptible pigeons. J Biol Chem. 1988;263:9612-9620.
44. Edwards IJ, Xu H, Obunike JC, Goldberg IJ, Wagner WD. Differentiated macrophages synthesize a heparan sulfate proteoglycan and an over-sulfated chondroitin sulfate proteoglycan that bind lipoprotein lipase. Arterioscler Thromb Vasc Biol. 1995;15:400-409.
45. Wasteson A. A method for the determination of the molecular weight and molecular weight distribution of chondroitin sulfate. J Chromatogr. 1971; 59:87-97.
46. Vogel T, Weisgraber KH, Zeevi MI, Ben-Artzi H, Levanon AZ, Rall SC Jr, Innerarity TL, Hui DY, Taylor JM, Kanner D, Yavin Z, Amit B, Aviv H, Gorecki M, Mahley RW. Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E. Proc Natl Acad Sci U S A. 1985;82:8696-8700.
47. Williams KJ, Fuki IV. Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism. Curr Opin Lipidol. 1997;8:253-262.
48. Freeman C, Hopwood J. In: Lane DA, et al, eds. Heparin and Related Polysaccharides. New York, NY: Plenum Press; 1992:121-133.
49. Pillarisetti S, Paka L, Sasaki A, Yin B, Parthasarathy N, Wagner WD, Goldberg IJ. Endothelial cell heparanase modulation of lipoprotein lipase activity: evidence that heparan sulfate oligosaccharide is an extracellular chaperone. J Biol Chem. 1997;272:15753-15759.
50. Tumova S, Bame KJ. The interaction between basic fibroblast growth factor and heparan sulfate can prevent the in vitro degradation of the glycosaminoglycan by Chinese hamster ovary cell heparanases. J Biol Chem. 1997;272:9078-9085.
51. Carey DJ. Syndecans: multifunctional cell-surface co-receptors. Biochem J. 1997;327:1-16.
52. Granot E, Schwiegelshohn B, Tabas I, Gorecki M, Vogel T, Carpentier YA, Deckelbaum RJ. Effects of particle size on cell uptake of model triglyceride-rich particles with and without apoprotein E. Biochemistry. 1994;33:15190-15197.
53. Chen CM, Vogel T, Sturley SL, Deckelbaum RJ. pH-dependent apolipoprotein E aggregation: a potential mechanism to escape intracellular degradation. Circulation, 1997;96(suppl I):I-346. Abstract.
54. Misra KB. Kim KC, Cho S, Low MG, Bensadoun A. Purification and characterization of adipocyte heparan sulfate proteoglycans with affinity for lipoprotein lipase. J Biol Chem. 1994;269:23838-23844.
55. Berryman DE, Bensadoun A. Heparan sulfate proteoglycans are primarily responsible for the maintenance of enzyme activity, binding, and degradation of lipoprotein lipase in Chinese hamster ovary cells. J Biol Chem. 1995;270:24525-24531.
56. Hurt-Camejo E, Olsson U, Wiklund O, Bondjers G, Camejo G. Cellular consequences of the association of apoB lipoproteins with proteoglycans: potential contribution to atherogenesis. Arterioscler Thromb Vasc Biol. 1997;17:1011-1017.
57. Clowes AW, Karnowsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature. 1977;265:625-626.
58. Vlodavsky I, Miao H, Medalion B, Danagher P, Ron D. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev. 1996; 15:177-186.
59. Kenagy RD, Nikkari ST, Welgus HG, Clowes AW. Heparin inhibits the induction of three matrix metalloproteases (stromelysin, 92 kD gelatinase and collagenase) in primate arterial smooth muscle cells. J Clin Invest. 1994;93:1987-1993.
60. Shirk RA, Church FC, Wagner WD. Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor II. Arterioscler Thromb Vasc Biol. 1996;16:1138-1146.
61. Hoppensteadt D, Walenga JM, Fareed J Comparative antithrombotic and hemorrhagic effects of DS, HS and heparin. Thromb Res. 1990;60: 191-200.
62. Obunike JC, Pillarisetti S, Paka L, Goldberg IJ. Lipoprotein lipase can function as monocyte adhesion protein. Arterioscler Thromb Vasc Biol. 1997;17:1414-1420.
63. Pillarisetti S, Paka L, Obunike JC, Berglund L, Goldberg IJ. Subendothelial retention of lipoprotein (a): evidence that reduced heparan sulfate promotes lipoprotein (a) retention by subendothelial matrix. J Clin Invest. 1997;100:867-874.
64. Linton MF, Atkinson JB, Fazio S. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 1995;267:1034-1037.
65. Fazio S, Babaev VR, Murray AB, Hasty AH, Carter KJ, Cleaves LA, Atkinson JB, Linton MF. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci U S A. 1997;94:4647-4652.